Cambrex is a leading supplier of products and services for the Life Sciences industry. We have built comprehensive technology platforms for use in small molecule API and advanced pharmaceutical intermediate synthesis, including enhanced drug delivery. Cambrex has extensive experience developing process to manufacture drug substances for clients use in tox. studies, clinical studies and commercial supply - from grams to tons. Our broad range of services include route selection, process & analytical development, process optimization & scale-up, safety assessments, and product formulation, in addition to an extensive list of generic APIs. Cambrex’s offerings include Controlled Substances, High Potency/Cytotoxics, Highly Energetic Chemistries, Polymeric Drug Delivery, Biocatalysis/Biotransformation, Chiral Synthesis, Hydrogenation, and Nitrations.
We have R&D and cGMP manufacturing facilities in the US and Europe, an excellent regulatory compliance record, and a strong expertise in various chemical technologies. We are committed to operating our facilities with the highest standards for regulatory, environmental, health, safety, and security guidelines. We have also adopted the Lean Six Sigma (LSS) Process to consistently deliver efficient, high quality, and cost competitive products with less time-to-market for our clients.
Our focus and goal is to provide solutions to large and small pharmaceutical companies with both established and emerging drug pipelines.
United States
